Proniosomes: a preferable carrier for drug delivery system

A B ST R A C T In recent time, proniosomal and noisomal system have been received a great attention in drug delivery applications as well as in pharmaceutical research. In order to minimize the problems associated with niosome physical stability such as aggregation, fusion and leaking and to provide additional convenience in transportation, distribution, storage and dosing etc, a dry product can be prepared, which is called proniosome. Proniosomes are dry formulation using suitable carrier coated with nonionic surfactants and can be converted into niosomes immediately before use by hydration. These proniosome-derived niosomes are as good as or even better than conventional niosomes. The current review deals with the trends, different aspects and the future perspective in the development of proniosomal drug delivery systems.

[1]  H. M. El-laithy,et al.  Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. , 2008, International journal of pharmaceutics.

[2]  M. Anwer,et al.  Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation , 2009, Journal of drug targeting.

[3]  R. Müller,et al.  Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.

[4]  Ijeoma F. Uchegbu,et al.  Non-ionic surfactant based vesicles (niosomes) in drug delivery , 1998 .

[5]  C. Puglia,et al.  Evaluation of in‐vivo topical anti‐inflammatory activity of indometacin from liposomal vesicles , 2004, The Journal of pharmacy and pharmacology.

[6]  J. Parikh,et al.  Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level box-behnken design , 2007, AAPS PharmSciTech.

[7]  S. Durga,et al.  Proniosomes as drug carriers. , 2010, Pakistan journal of pharmaceutical sciences.

[8]  N. Jain,et al.  Proniosome based transdermal delivery of levonorgestrel for effective contraception. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[9]  A. Fahr,et al.  Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  N. Udupa,et al.  Formulation and in vitro evaluation of vincristine encapsulated niosomes , 1994 .

[11]  J. Parikh,et al.  PREPARATION, CHARACTERIZATION, OPTIMIZATION, AND STABILITY STUDIES OF ACECLOFENAC PRONIOSOMES , 2008 .

[12]  A. Florence,et al.  The preparation and properties of niosomes—non‐ionic surfactant vesicles , 1985, The Journal of pharmacy and pharmacology.

[13]  N. K. Jain,et al.  Niosomes As Drug Carriers , 1996 .

[14]  S. Talegaonkar,et al.  Vesicular systems: An overview , 2006 .

[15]  S. Baboota,et al.  Pharmacodynamic evaluation of proniosomal transdermal therapeutic gel containing celecoxib , 2010 .

[16]  O. Sammour,et al.  Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. , 2008, International journal of pharmaceutics.

[17]  G. H. Coombs,et al.  Vesicular Systems (Niosomes and Liposomes) for Delivery of Sodium Stibogluconate in Experimental Murine Visceral Leishmaniasis , 1988, The Journal of pharmacy and pharmacology.

[18]  B. Prajapati,et al.  Effect of hydrophilic polymers on buccoadhesive eudragit patches of propranolol hydrochloride using factorial design , 2007, AAPS PharmSciTech.

[19]  D. Rhodes,et al.  SEM Imaging Predicts Quality of Niosomes from Maltodextrin-Based Proniosomes , 2001, Pharmaceutical Research.

[20]  Y. Huang,et al.  Evaluation of pharmacokinetics and pharmacodynamics of captopril from transdermal hydrophilic gels in normotensive rabbits and spontaneously hypertensive rats. , 2000, International journal of pharmaceutics.

[21]  Ankur Gupta,et al.  Design and Development of a Proniosomal Transdermal Drug Delivery System for Captopril , 2007 .

[22]  V. Junyaprasert,et al.  Effect of Charged and Non-ionic Membrane Additives on Physicochemical Properties and Stability of Niosomes , 2008, AAPS PharmSciTech.

[23]  S. Vemuri,et al.  In Vitro Interaction of Sized and Unsized Liposome Vesicles with High Density Lipo Proteins , 1990 .

[24]  A. Pardakhty,et al.  Sorbitan Monopalmitate-Based Proniosomes for Transdermal Delivery of Chlorpheniramine Maleate , 2005, Drug delivery.

[25]  B. W. Barry,et al.  Novel mechanisms and devices to enable successful transdermal drug delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[26]  D. Rhodes,et al.  Proniosomes: a novel drug carrier preparation. , 1999, International journal of pharmaceutics.

[27]  Sayed M. Ahmed,et al.  Proniosomes as a drug carrier for transdermal delivery of ketorolac. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[28]  J. Fang,et al.  In vitro skin permeation of estradiol from various proniosome formulations. , 2001, International journal of pharmaceutics.

[29]  A. Florence,et al.  Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85) , 1994 .

[30]  O. Sammour,et al.  In Vitro Evaluation of Proniosomes as a Drug Carrier for Flurbiprofen , 2008, AAPS PharmSciTech.

[31]  R. Devraj,et al.  Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. , 2002, Journal of colloid and interface science.

[32]  A. Florence,et al.  The effect of non‐ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice , 1985, The Journal of pharmacy and pharmacology.

[33]  Venkatesh,et al.  Niosomal Sumartriptan Succinate For Nasal Administration , 2000 .

[34]  J. Cummings,et al.  Adriamycin-loaded niosomes: drug entrapment, stability and release. , 1987, Journal of microencapsulation.

[35]  S. B. Tiwari,et al.  Niosome entrapped ß-cyclodextrin methotrexate complex as a drug delivery system , 1999 .

[36]  H. Junginger,et al.  Niosomes for oral delivery of peptide drugs , 1992 .

[37]  N. Udupa,et al.  Pharmacokinetic evaluation of surfactant vesicle-entrapped methotrexate in tumor-bearing mice , 1990 .

[38]  K. Li,et al.  Studies on a high encapsulation of colchicine by a niosome system. , 2002, International journal of pharmaceutics.

[39]  M. Marchand-Arvier,et al.  [Hemoglobin niosomes. I. Preparation, functional and physico-chemical properties, and stability]. , 1989, Pharmaceutica Acta Helvetiae.

[40]  Ra,et al.  Proniosome based drug delivery system of piroxicam , 2008 .

[41]  A. Rawat,et al.  Tetanus toxoid‐loaded transfersomes for topical immunization , 2005, The Journal of pharmacy and pharmacology.

[42]  G. Gregoriadis.  TARGETING OF DRUGS: IMPLICATIONS IN MEDICINE , 1981, The Lancet.

[43]  D. Rhodes,et al.  Maltodextrin-based proniosomes , 2001, AAPS PharmSci.

[44]  S. Chan,et al.  Transdermal delivery of haloperidol by proniosomal formulations with non-ionic surfactants. , 2009, Biological & pharmaceutical bulletin.

[45]  J. Cummings,et al.  The Distribution of Doxorubicin in Mice Following Administration in Niosomes , 1988, The Journal of pharmacy and pharmacology.

[46]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[47]  A. ElMeshad,et al.  Comparative Study on the Effects of Some Polyoxyethylene Alkyl Ether and Sorbitan Fatty Acid Ester Surfactants on the Performance of Transdermal Carvedilol Proniosomal Gel Using Experimental Design , 2010, AAPS PharmSciTech.